Table 2.
Prevalence proportion ratios (PPR) and 95% confidence intervals (CI) evaluating the relationship with the presence of chronic health conditions (CHC) and COVID-19 testing and vaccination among American Indian/Alaska Native survey respondents in Oklahoma.
| Variable | CHC Present N (W%)a |
CHC Absent N (W%)a |
Unadjusted PPR (95% CI) |
Adjustedb PPR (95% CI) |
|---|---|---|---|---|
| Ever Tested for COVID-19 | ||||
| Yes | 653 (82.7) | 281 (77.2) | 1.07 (0.96, 1.18) | 1.08 (0.97, 1.19) |
| No | 132 (17.3) | 73 (22.8) | Referent | Referent |
| Ease of Testing Access | ||||
| Easy | 650 (83.5) | 293 (78.6) | 1.06 (0.94, 1.19) | 1.08 (0.95, 1.21) |
| Not Easy | 135 (16.5) | 61 (21.4) | Referent | Referent |
| Vaccine Uptake | ||||
| Yes | 565 (60.9) | 200 (52.4) | 1.16 (0.96, 1.37) | 1.08 (0.90, 1.27) |
| No | 220 (39.1) | 154 (47.6) | Referent | Referent |
| Likelihood of Getting a COVID-19 Vaccinec | ||||
| Likely | 54 (28.2) | 31 (15.5) | 1.85 (1.01, 2.69) | 1.81 (1.01, 2.62) |
| Not Likely | 167 (71.8) | 123 (84.5) | Referent | Referent |
a
Counts are raw pooled counts with weighted percentages (W%)
b
Based on DAG: age, gender, education, family income, healthcare/transportation challenges, lifetime alcohol use, current smoking status, and current e-cigarette status
c
Among respondents with no previous vaccine doses (n=221 with CHC, n=154 without CHC)